abstract |
The present invention relates to biaryl PDE4 inhibitors of the general formula Ib, Ic or Id for use in the treatment of pulmonary and cardiovascular disorders, in particular for the treatment and prevention of e.g. stroke, myocardial infarction and cardiovascular inflammatory diseases and disorders . |